Sascha received his B.S. in Biology at UC Davis before completing his PhD in Pharmacology at the University of Colorado Anschutz Medical Campus. His work focused on how TGFβ signaling impacts immunotherapy in head and neck cancer. Sascha has held a variety of positions including lab manager at the University of Washington, lab manager at Fred Hutchinson Cancer Research Center, and scientific writer at Scientific and Medical Affairs Consulting, LLC before joining OnKure Therapeutics as a pharmacology research scientist. In this position, he manages ADME and PKPD/efficacy studies, organizes and maintains data, and develops experiments to quantify and optimize in vivo drug properties for material with in vitro activity.
Reservation Policy & Attendance Limit: This event has an attendance limit of 300 people and seats will be reserved on a first-come, first-served basis. Please be sure to register as soon as possible to reserve your seat and ensure your attendance.
*We strive to be inclusive. All are welcome to attend!